-
Je něco špatně v tomto záznamu ?
In vivo study of the effect of antiviral acyclic nucleotide phosphonate (R)-9-[2- (phosphonomethoxy) propyl]adenine (PMPA, tenofovir) and its prodrug tenofovir disoproxil fumarate on rat microsomal cytochrome P450
E. Anzenbacherová, P. Anzenbacher, Z. Zídek, E. Buchar, E. Kmoníčková, P. Potměšil, J. Nekvindová, A. Veinlichová, A. Holý
Jazyk angličtina Země Česko
NLK
Directory of Open Access Journals
od 1991
Free Medical Journals
od 1998
ProQuest Central
od 2005-01-01
Medline Complete (EBSCOhost)
od 2006-01-01
Nursing & Allied Health Database (ProQuest)
od 2005-01-01
Health & Medicine (ProQuest)
od 2005-01-01
ROAD: Directory of Open Access Scholarly Resources
od 1998
- Klíčová slova
- PMPA, Cytochrome P450, CYP2E1, CYP1A2,
- MeSH
- adenin analogy a deriváty aplikace a dávkování farmakologie MeSH
- antivirové látky aplikace a dávkování farmakologie MeSH
- cytochrom P-450 CYP1A2 genetika metabolismus MeSH
- cytochrom P-450 CYP2E1 genetika metabolismus MeSH
- cytochromy metabolismus MeSH
- denaturace proteinů MeSH
- down regulace MeSH
- financování organizované MeSH
- injekce intraperitoneální MeSH
- jaterní mikrozomy MeSH
- játra enzymologie účinky léků MeSH
- krysa rodu rattus MeSH
- messenger RNA metabolismus MeSH
- organofosfonáty aplikace a dávkování farmakologie MeSH
- potkani inbrední LEW MeSH
- prekurzory léčiv aplikace a dávkování farmakologie MeSH
- tenofovir MeSH
- zvířata MeSH
- Check Tag
- krysa rodu rattus MeSH
- ženské pohlaví MeSH
- zvířata MeSH
The total content of rat liver microsomal cytochrome P450 (CYP) significantly decreased after repeated i.p. administration of the antiviral agent tenofovir ((R)-9-[2-(phosphonomethoxy)propyl] adenine) and tenofovir disoproxil at a daily dose 25 mg/kg, although the content of liver microsomal protein did not change. The decrease of the CYP content was accompanied by concomitant increase of the amount of inactive CYP form, cytochrome P420. This effect was confirmed by a parallel study of the activities of selected CYP forms, CYP2E1 (p-nitrophenol hydroxylation) and CYP1A2 (7-ethoxyresorufin deethylation). The activity (expressed relatively to the protein content) of both CYP forms decreased significantly following the decrease of the total CYP. On the other hand, the CYP2E1 activity expressed relatively to the decreasing total CYP content remained unchanged. However, CYP1A2 activity also decreased when calculated relatively to the total native CYP content indicating lower stability of this form. Semiquantitative RT-PCR showed no significant changes in expression of major rat liver microsomal CYP forms after tenofovir treatment. In conclusion, repeated administration of tenofovir in higher doses led to significant decrease of the relative proportion of active liver microsomal CYPs accompanied by a conversion of these enzymes to the inactive form (CYP420) maintaining the sum of CYP proteins unchanged.
Citace poskytuje Crossref.org
Lit.: 17
- 000
- 00000naa 2200000 a 4500
- 001
- bmc10015699
- 003
- CZ-PrNML
- 005
- 20130204145931.0
- 008
- 100726s2008 xr e eng||
- 009
- AR
- 024 7_
- $a 10.33549/physiolres.931319 $2 doi
- 040 __
- $a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xr
- 100 1_
- $a Anzenbacherová, Eva, $d 1959- $7 stk2008428613
- 245 10
- $a In vivo study of the effect of antiviral acyclic nucleotide phosphonate (R)-9-[2- (phosphonomethoxy) propyl]adenine (PMPA, tenofovir) and its prodrug tenofovir disoproxil fumarate on rat microsomal cytochrome P450 / $c E. Anzenbacherová, P. Anzenbacher, Z. Zídek, E. Buchar, E. Kmoníčková, P. Potměšil, J. Nekvindová, A. Veinlichová, A. Holý
- 314 __
- $a Institute of Medical Chemistry and Biochemistry, Academy of Sciences of the Czech Republic, Prague, Czech Republic
- 504 __
- $a Lit.: 17
- 520 9_
- $a The total content of rat liver microsomal cytochrome P450 (CYP) significantly decreased after repeated i.p. administration of the antiviral agent tenofovir ((R)-9-[2-(phosphonomethoxy)propyl] adenine) and tenofovir disoproxil at a daily dose 25 mg/kg, although the content of liver microsomal protein did not change. The decrease of the CYP content was accompanied by concomitant increase of the amount of inactive CYP form, cytochrome P420. This effect was confirmed by a parallel study of the activities of selected CYP forms, CYP2E1 (p-nitrophenol hydroxylation) and CYP1A2 (7-ethoxyresorufin deethylation). The activity (expressed relatively to the protein content) of both CYP forms decreased significantly following the decrease of the total CYP. On the other hand, the CYP2E1 activity expressed relatively to the decreasing total CYP content remained unchanged. However, CYP1A2 activity also decreased when calculated relatively to the total native CYP content indicating lower stability of this form. Semiquantitative RT-PCR showed no significant changes in expression of major rat liver microsomal CYP forms after tenofovir treatment. In conclusion, repeated administration of tenofovir in higher doses led to significant decrease of the relative proportion of active liver microsomal CYPs accompanied by a conversion of these enzymes to the inactive form (CYP420) maintaining the sum of CYP proteins unchanged.
- 650 _2
- $a financování organizované $7 D005381
- 650 _2
- $a adenin $x analogy a deriváty $x aplikace a dávkování $x farmakologie $7 D000225
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a antivirové látky $x aplikace a dávkování $x farmakologie $7 D000998
- 650 _2
- $a cytochrom P-450 CYP1A2 $x genetika $x metabolismus $7 D019388
- 650 _2
- $a cytochrom P-450 CYP2E1 $x genetika $x metabolismus $7 D019392
- 650 _2
- $a cytochromy $x metabolismus $7 D003580
- 650 _2
- $a down regulace $7 D015536
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a injekce intraperitoneální $7 D007274
- 650 _2
- $a játra $x enzymologie $x účinky léků $7 D008099
- 650 _2
- $a jaterní mikrozomy $7 D008862
- 650 _2
- $a organofosfonáty $x aplikace a dávkování $x farmakologie $7 D063065
- 650 _2
- $a prekurzory léčiv $x aplikace a dávkování $x farmakologie $7 D011355
- 650 _2
- $a denaturace proteinů $7 D011489
- 650 _2
- $a messenger RNA $x metabolismus $7 D012333
- 650 _2
- $a krysa rodu Rattus $7 D051381
- 650 _2
- $a potkani inbrední LEW $7 D011917
- 650 _2
- $a tenofovir $7 D000068698
- 653 00
- $a PMPA
- 653 00
- $a Cytochrome P450
- 653 00
- $a CYP2E1
- 653 00
- $a CYP1A2
- 700 1_
- $a Anzenbacher, Pavel, $d 1947- $7 xx0034447
- 700 1_
- $a Zídek, Zdeněk $7 jk01152582
- 700 1_
- $a Buchar, Evžen $7 xx0079768
- 700 1_
- $a Potměšil, Petr $7 xx0102562
- 700 1_
- $a Nekvindová, Jana. $7 xx0207729
- 700 1_
- $a Veinlichová, A. $7 _AN051220
- 700 1_
- $a Holý, Antonín, $d 1936-2012 $7 jn20000401004
- 700 1_
- $a Kmoníčková, Eva, $d 1962- $7 jo2002105217
- 773 0_
- $w MED00003824 $t Physiological research $g Roč. 57, č. 5 (2008), s. 761-767 $x 0862-8408
- 856 41
- $u http://www.biomed.cas.cz/physiolres/pdf/57/57_761.pdf $y plný text volně přístupný
- 910 __
- $a ABA008 $b A 4120 $c 266 $y 8
- 990 __
- $a 20100708110758 $b ABA008
- 991 __
- $a 20120717123111 $b ABA008
- 999 __
- $a ok $b bmc $g 756114 $s 619895
- BAS __
- $a 3
- BMC __
- $a 2008 $b 57 $c 5 $m Physiological research $x MED00003824 $d 761-767
- LZP __
- $a 2010-32/vtme